KCR S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
KCR S.A. - overview
Established
1997
Location
Warsaw, -, Poland
Primary Industry
Business Support Services
About
KCR S. A. is a clinical research organization that specializes in providing consulting services to the biotechnology and pharmaceutical sectors, focusing on improving drug development processes. Founded in 1997, KCR S.
A. operates as a clinical research organization based in Warsaw, Poland. The company has engaged in 2 deals to date, with its most recent deal occurring on August 21, 2013, when it was acquired by Argus Capital Group. The company is led by CEO Devdatta D, alongside Kcr Kehar and Kelly Coelho.
KCR S. A. offers a range of clinical research and consulting services tailored for the biotechnology and pharmaceutical industries. Their core areas include clinical trial management and regulatory affairs consulting, which support companies in navigating the complexities of drug development from initial stages through to post-marketing.
They work with various therapeutic areas, ensuring their services meet the needs of diverse clients, including small to mid-sized biopharmaceutical firms. In the most recent fiscal year of 2023, KCR S. A. reported a revenue of USD 40.
92 mn and an EBITDA of USD 332,345. 9. KCR S. A.
is focused on expanding its operations further into the global market and enhancing its service offerings. Although specific upcoming product launches are not detailed, recent funding will be directed towards developing new service models and strengthening international partnerships. The company aims to leverage its strategic initiatives to enhance its presence in key markets, but specific target regions or release dates for new products have not been disclosed.
Current Investors
ARGUS Capital Group
Primary Industry
Business Support Services
Sub Industries
Consulting Services, Biotechnology, Pharmaceuticals
Website
https://www.kcrcro.com
Verticals
Big Data
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
KCR S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | KCR S.A. | - | ||||||||
| Buyout | Completed | KCR S.A. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.